Fosaprepitant Interactions
There are 445 drugs known to interact with fosaprepitant, along with 1 disease interaction. Of the total drug interactions, 74 are major, 346 are moderate, and 25 are minor.
- View all 445 medications that may interact with fosaprepitant
- View fosaprepitant disease interactions (1)
Most frequently checked interactions
View interaction reports for fosaprepitant and the medicines listed below.
- Abraxane (paclitaxel protein-bound)
- Adriamycin (doxorubicin)
- Alimta (pemetrexed)
- Aloxi (palonosetron)
- Benadryl (diphenhydramine)
- Claritin (loratadine)
- Compazine (prochlorperazine)
- CoQ10 (ubiquinone)
- Decadron (dexamethasone)
- Eliquis (apixaban)
- Enhertu (fam-trastuzumab deruxtecan)
- Fish Oil (omega-3 polyunsaturated fatty acids)
- Imitrex (sumatriptan)
- Imodium (loperamide)
- Keytruda (pembrolizumab)
- Metoprolol Succinate ER (metoprolol)
- Metoprolol Tartrate (metoprolol)
- MiraLAX (polyethylene glycol 3350)
- Morphine Sulfate ER (morphine)
- Neulasta (pegfilgrastim)
- Tagrisso (osimertinib)
- Trelegy Ellipta (fluticasone / umeclidinium / vilanterol)
- Tylenol (acetaminophen)
- Ventolin HFA (albuterol)
- Vitamin B12 (cyanocobalamin)
- Vitamin B6 (pyridoxine)
- Vitamin C (ascorbic acid)
- Vitamin D3 (cholecalciferol)
- Zofran (ondansetron)
- Zyrtec (cetirizine)
Fosaprepitant disease interactions
There is 1 disease interaction with fosaprepitant which include:
Report options
QR code containing a link to this page
More about fosaprepitant
- fosaprepitant consumer information
- Compare alternatives
- Pricing & coupons
- Reviews (1)
- Side effects
- Dosage information
- During pregnancy
- Drug class: NK1 receptor antagonists
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
